Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
2,910
JPY
|
+1.66%
|
|
+6.07%
|
-9.26%
|
Fiscal Period: May |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
234,855
|
257,611
|
247,213
|
174,373
|
233,968
|
275,274
|
-
|
-
|
Enterprise Value (EV)
1 |
256,012
|
277,902
|
284,494
|
224,121
|
278,266
|
318,066
|
313,784
|
307,031
|
P/E ratio
|
22.1
x
|
20.7
x
|
20.5
x
|
17.7
x
|
19
x
|
23.8
x
|
15.6
x
|
14.4
x
|
Yield
|
0.24%
|
0.24%
|
0.29%
|
0.47%
|
0.39%
|
0.38%
|
0.54%
|
0.6%
|
Capitalization / Revenue
|
0.94
x
|
0.86
x
|
0.81
x
|
0.53
x
|
0.62
x
|
0.63
x
|
0.58
x
|
0.53
x
|
EV / Revenue
|
1.02
x
|
0.93
x
|
0.93
x
|
0.68
x
|
0.73
x
|
0.73
x
|
0.66
x
|
0.6
x
|
EV / EBITDA
|
13
x
|
12.3
x
|
11.9
x
|
9.81
x
|
10.4
x
|
10.8
x
|
8.19
x
|
7.44
x
|
EV / FCF
|
-49.3
x
|
81.4
x
|
-28.8
x
|
-29.9
x
|
31
x
|
-110
x
|
107
x
|
52.1
x
|
FCF Yield
|
-2.03%
|
1.23%
|
-3.47%
|
-3.34%
|
3.23%
|
-0.91%
|
0.94%
|
1.92%
|
Price to Book
|
4.32
x
|
3.9
x
|
3.19
x
|
2.01
x
|
2.38
x
|
2.51
x
|
2.26
x
|
1.98
x
|
Nbr of stocks (in thousands)
|
94,572
|
94,594
|
94,597
|
94,597
|
94,596
|
94,596
|
-
|
-
|
Reference price
2 |
2,483
|
2,723
|
2,613
|
1,843
|
2,473
|
2,910
|
2,910
|
2,910
|
Announcement Date
|
7/4/19
|
7/2/20
|
7/1/21
|
7/4/22
|
6/30/23
|
-
|
-
|
-
|
Fiscal Period: May |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
250,885
|
300,173
|
305,880
|
328,335
|
378,874
|
436,120
|
474,420
|
515,360
|
EBITDA
1 |
19,689
|
22,634
|
23,914
|
22,856
|
26,760
|
29,486
|
38,300
|
41,288
|
EBIT
1 |
14,147
|
16,359
|
16,619
|
14,070
|
15,296
|
17,700
|
25,680
|
27,820
|
Operating Margin
|
5.64%
|
5.45%
|
5.43%
|
4.29%
|
4.04%
|
4.06%
|
5.41%
|
5.4%
|
Earnings before Tax (EBT)
1 |
14,476
|
17,190
|
16,825
|
14,579
|
16,760
|
17,900
|
26,500
|
28,933
|
Net income
1 |
10,648
|
12,416
|
12,062
|
9,839
|
12,326
|
11,980
|
18,360
|
19,900
|
Net margin
|
4.24%
|
4.14%
|
3.94%
|
3%
|
3.25%
|
2.75%
|
3.87%
|
3.86%
|
EPS
2 |
112.6
|
131.3
|
127.5
|
104.0
|
130.3
|
122.5
|
186.3
|
201.8
|
Free Cash Flow
1 |
-5,193
|
3,413
|
-9,877
|
-7,485
|
8,989
|
-2,900
|
2,934
|
5,896
|
FCF margin
|
-2.07%
|
1.14%
|
-3.23%
|
-2.28%
|
2.37%
|
-0.66%
|
0.62%
|
1.14%
|
FCF Conversion (EBITDA)
|
-
|
15.08%
|
-
|
-
|
33.59%
|
-
|
7.66%
|
14.28%
|
FCF Conversion (Net income)
|
-
|
27.49%
|
-
|
-
|
72.93%
|
-
|
15.98%
|
29.63%
|
Dividend per Share
2 |
6.000
|
6.667
|
7.667
|
8.667
|
9.667
|
10.92
|
15.63
|
17.35
|
Announcement Date
|
7/4/19
|
7/2/20
|
7/1/21
|
7/4/22
|
6/30/23
|
-
|
-
|
-
|
Fiscal Period: May |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
146,435
|
150,716
|
80,562
|
161,192
|
84,663
|
82,480
|
91,766
|
92,515
|
184,281
|
97,946
|
96,647
|
107,439
|
108,183
|
215,622
|
111,088
|
108,812
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
6,629
|
8,481
|
3,494
|
6,805
|
4,204
|
3,061
|
4,476
|
3,802
|
8,278
|
4,462
|
3,485
|
6,660
|
160
|
6,820
|
6,659
|
4,100
|
-
|
-
|
-
|
-
|
Operating Margin
|
4.53%
|
5.63%
|
4.34%
|
4.22%
|
4.97%
|
3.71%
|
4.88%
|
4.11%
|
4.49%
|
4.56%
|
3.61%
|
6.2%
|
0.15%
|
3.16%
|
5.99%
|
3.77%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
6,812
|
8,743
|
-
|
6,995
|
4,682
|
2,902
|
5,952
|
5,041
|
10,993
|
5,534
|
1,162
|
6,810
|
211
|
7,021
|
6,900
|
3,317
|
-
|
-
|
-
|
-
|
Net income
1 |
4,889
|
6,435
|
2,347
|
4,694
|
3,027
|
2,118
|
4,144
|
3,780
|
7,924
|
4,032
|
1,016
|
4,789
|
-1,367
|
3,422
|
4,844
|
2,006
|
-
|
-
|
-
|
-
|
Net margin
|
3.34%
|
4.27%
|
2.91%
|
2.91%
|
3.58%
|
2.57%
|
4.52%
|
4.09%
|
4.3%
|
4.12%
|
1.05%
|
4.46%
|
-1.26%
|
1.59%
|
4.36%
|
1.84%
|
-
|
-
|
-
|
-
|
EPS
2 |
51.69
|
68.03
|
24.81
|
49.63
|
31.99
|
22.39
|
43.81
|
39.96
|
83.77
|
42.62
|
10.74
|
50.63
|
-14.45
|
36.18
|
51.21
|
35.23
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
3.333
|
3.750
|
4.333
|
4.333
|
-
|
4.333
|
-
|
4.833
|
4.833
|
-
|
4.833
|
-
|
5.333
|
5.333
|
-
|
5.500
|
-
|
6.333
|
-
|
6.333
|
Announcement Date
|
12/12/19
|
12/21/20
|
1/4/22
|
1/4/22
|
3/30/22
|
7/4/22
|
10/3/22
|
12/28/22
|
12/28/22
|
4/4/23
|
6/30/23
|
10/3/23
|
12/28/23
|
12/28/23
|
4/4/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: May |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
21,157
|
20,291
|
37,281
|
49,748
|
44,298
|
42,791
|
38,510
|
31,756
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.075
x
|
0.8965
x
|
1.559
x
|
2.177
x
|
1.655
x
|
1.451
x
|
1.005
x
|
0.7692
x
|
Free Cash Flow
1 |
-5,193
|
3,413
|
-9,877
|
-7,485
|
8,989
|
-2,900
|
2,934
|
5,896
|
ROE (net income / shareholders' equity)
|
21.6%
|
20.6%
|
16.8%
|
12%
|
13.3%
|
11.1%
|
15.5%
|
14.6%
|
ROA (Net income/ Total Assets)
|
11.5%
|
11%
|
9.48%
|
7.34%
|
7.88%
|
5.48%
|
7.23%
|
7.22%
|
Assets
1 |
92,471
|
113,091
|
127,294
|
134,049
|
156,440
|
218,553
|
253,907
|
275,766
|
Book Value Per Share
2 |
575.0
|
699.0
|
820.0
|
918.0
|
1,041
|
1,159
|
1,287
|
1,472
|
Cash Flow per Share
|
171.0
|
198.0
|
205.0
|
197.0
|
251.0
|
-
|
-
|
-
|
Capex
1 |
16,335
|
15,415
|
22,041
|
29,288
|
30,395
|
24,550
|
27,240
|
27,280
|
Capex / Sales
|
6.51%
|
5.14%
|
7.21%
|
8.92%
|
8.02%
|
5.63%
|
5.74%
|
5.29%
|
Announcement Date
|
7/4/19
|
7/2/20
|
7/1/21
|
7/4/22
|
6/30/23
|
-
|
-
|
-
|
Last Close Price
2,910
JPY Average target price
3,625
JPY Spread / Average Target +24.57% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.26% | 1.75B | | -11.64% | 3.62B | | -0.09% | 3.36B | | -23.44% | 3.06B | | +7.56% | 2.67B | | +9.74% | 2.59B | | +9.30% | 1.35B | | -18.45% | 957M | | -38.18% | 704M | | -1.85% | 370M |
Retail - Drugs with Grocery
|